Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 37133585

Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2023 May 4
First author
Prager GW

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2023 Aug;20(8):504. doi: 10.1038/s41571-023-00784-9.
    note
    Source null
    related pmid
    37198414
    relationship
    Comment in
  2. citation
    N Engl J Med. 2023 Jul 13;389(2):190. doi: 10.1056/NEJMc2306486.
    note
    Source null
    related pmid
    37437152
    relationship
    Comment in
  3. citation
    N Engl J Med. 2023 Jul 13;389(2):190-191. doi: 10.1056/NEJMc2306486.
    note
    Source null
    related pmid
    37437153
    relationship
    Comment in

Authors and identifiers

  1. name
    Prager GW
    type
    Author
  2. name
    Taieb J
    type
    Author
  3. name
    Fakih M
    type
    Author
  4. name
    Ciardiello F
    type
    Author
  5. name
    Van Cutsem E
    type
    Author
  6. name
    Elez E
    type
    Author
  7. name
    Cruz FM
    type
    Author
  8. name
    Wyrwicz L
    type
    Author
  9. name
    Stroyakovskiy D
    type
    Author
  10. name
    Pápai Z
    type
    Author
  11. name
    Poureau PG
    type
    Author
  12. name
    Liposits G
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Prager GW
    type
    Author
  2. name
    Taieb J
    type
    Author
  3. name
    Fakih M
    type
    Author
  4. name
    Ciardiello F
    type
    Author
  5. name
    Van Cutsem E
    type
    Author
  6. name
    Elez E
    type
    Author
  7. name
    Cruz FM
    type
    Author
  8. name
    Wyrwicz L
    type
    Author
  9. name
    Stroyakovskiy D
    type
    Author
  10. name
    Pápai Z
    type
    Author
  11. name
    Poureau PG
    type
    Author
  12. name
    Liposits G
    type
    Author
bibliography ids
  1. nci-bib-3d8befecd1c3f59c7afa8e91
book metadata
content sha256
015a44914ae097294797663c5ab07da1e41a77bd426d1027e62b6429c0e4d41d
document type
citation
dois
  1. 10.1056/NEJMoa2214963
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:37133585
immutable id
pubmed:37133585@015a44914ae097294797663c5ab07da1e41a77bd426d1027e62b6429c0e4d41d
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
18
name
The New England journal of medicine
nlm unique id
0255562
pages
1657-1667
volume
388
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2023 Aug;20(8):504. doi: 10.1038/s41571-023-00784-9.
    note
    Source null
    related pmid
    37198414
    relationship
    Comment in
  2. citation
    N Engl J Med. 2023 Jul 13;389(2):190. doi: 10.1056/NEJMc2306486.
    note
    Source null
    related pmid
    37437152
    relationship
    Comment in
  3. citation
    N Engl J Med. 2023 Jul 13;389(2):190-191. doi: 10.1056/NEJMc2306486.
    note
    Source null
    related pmid
    37437153
    relationship
    Comment in
outcomes validated
false
pmid
37133585
provenance
batch id
5329a5d0877ee70ecd11
provider
NCBI PubMed ESummary
record sha256
8a8ff0c8e3998d066aafb81bb8e73d94260c170959cdb6a312be2597c9c4d498
response sha256
bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
retrieved at
2026-09-09T23:48:15.763286+00:00
publication date
display
2023 May 4
precision
day
year
2023
publication types
  1. Journal Article
  2. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/37133585/
title
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.

Preserved source evidence · Independent clinical review pending · Not medical advice